EnClear Therapies, Inc.
65 Parker Street #3A. Newburyport, MA 01950

©2018 by EnClear Therapies. Proudly created with Wix.com

Media & Press Updates

News and updates about EnClear Therapies, as well as industry news and analysis. If you have any questions about our articles, please get in touch today.

December 31, 2018

Medical device startups are becoming increasingly ambitious when it comes to treating diseases that are ill-served by drugs. The latest on this front is Enclear Therapies Inc., a Cambridge, Mass.-based company that is developing a device to clear toxic proteins from cerebrospinal fluid (CSF) to treat diseases such as amyotrophic lateral sclerosis (ALS), progressive supranuclear palsy (PSP) and other neurological diseases.

December 27, 2018

Medical Device Developer EnClear Spins out of QurAlis biotech company focused on developing precision therapeutics for ALS and other neurological diseases. EnClear’s mission is to halt the progression of disease and extend the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP) by removing toxic proteins that build up in the brain and spinal cord, significantly impacting neurodegeneration.

EnClear to present at the Biotech Showcase 2019

December 27, 2018

EnClear Therapies will present at the Biotech Showcase 2019 conference, occurring January
7-9, 2019 at the Hilton San Francisco Union Square in San Francisco. Mr. DePasqua is scheduled to
present on Wednesday, January 9, 2019, 3:10 PM, Track: Franciscan C (Ballroom Level).